ZEVRA THERAPEUTICS, INC. Annual Income Tax Expense (Benefit) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Zevra Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2013 to 2023.
  • Zevra Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $0.000, a 100% decline year-over-year.
  • Zevra Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $0.000, a 100% decline year-over-year.
  • Zevra Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000.
  • Zevra Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was -$33K, a 197% decline from 2021.
  • Zevra Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $34K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0 +$33K Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 -$33K -$67K -197% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $34K +$68K Jan 1, 2021 Dec 31, 2021 10-K 2023-03-07
2020 -$34K -$12K -54.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 -$22K +$104K +82.5% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
2018 -$126K -$83K -193% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-28
2017 -$43K -$28K -187% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-01
2016 -$15K -$41K -158% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-30
2015 $26K +$48K Jan 1, 2015 Dec 31, 2015 10-K 2018-03-30
2014 -$22K -$2K -10% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-10
2013 -$20K Jan 1, 2013 Dec 31, 2013 10-K 2016-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.